EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sequential and Long-term Therapy for Osteoporosis

Michael R McClung

Current Osteoporosis Reports · 2025-12 · 23 (1)

DOI: 10.1007/s11914-025-00909-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Osteoporosis Reports, online erschienen am 22.03.2025. Verfasst von Michael R McClung. Beteiligte Einrichtung: Founding and Emeritus Director, Oregon Osteoporosis Center, Portland, OR, United States of America. mmcclung.ooc@gmail.com. Hauptthemen laut MEDLINE: Bone Density Conservation Agents, Osteoporosis, Diphosphonates. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 100 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE OF THE REVIEW: Osteoporosis requires life-long management. This involves the use of different drugs in various sequences followed by long-term maintenance therapy. This review highlights the important transitions among osteoporosis therapies and outlines a strategy of intermittent bisphosphonate therapy for long-term maintenance. RECENT FINDINGS: Over the past few years, the effects and limitations of long-term treatment with bisphosphonates and denosumab have become apparent as have several key factors in the sequential use of anti-remodeling drugs and osteoanabolic agents. Strategies for transitions from estrogen, bisphosphonates, denosumab and the bone-forming drugs will be discussed, based on extant evidence, clinical experience and expert opinion. By appropriate selection of both the initial and subsequent drugs for the prevention and treatment of osteoporosis, therapeutic benefits can be optimized and safety issues minimized. Developing a strategy for long-term maintenance of the benefits of the initial therapies can provide a life plan for managing patients with osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Density Conservation AgentsOsteoporosisDiphosphonatesHumansDenosumabEstrogens

Stichwörter der Autor:innen

Bisphosphonate holidayDenosumab discontinuationMaintenance therapyOsteoporosisTreatment sequence

Substanzen

Bone Density Conservation AgentsDenosumabDiphosphonatesEstrogens

Autor:innen und Institutionen

  • Founding and Emeritus Director, Oregon Osteoporosis Center, Portland, OR, United States of America. mmcclung.ooc@gmail.com.

Zitieren

APA

McClung, M. R. (2025). Sequential and Long-term Therapy for Osteoporosis. Current Osteoporosis Reports, 23(1). https://doi.org/10.1007/s11914-025-00909-2

Vancouver

McClung MR. Sequential and Long-term Therapy for Osteoporosis. Current Osteoporosis Reports. 2025;23(1). doi:10.1007/s11914-025-00909-2

BibTeX
@article{McClung2025,
  author = {McClung, Michael R},
  title = {Sequential and Long-term Therapy for Osteoporosis},
  journal = {Current Osteoporosis Reports},
  year = {2025},
  volume = {23},
  number = {1},
  doi = {10.1007/s11914-025-00909-2}
}
Kostenlos starten →